Rubicon Organics to Release Q3 2025 Financial Results and Expand Production Capacity

Rubicon Organics ( (TSE:ROMJ) ) has provided an announcement.

Rubicon Organics announced it will release its Q3 2025 financial results on November 12, 2025, followed by a conference call on November 13, 2025. The company is expanding its production capacity by over 40% with the acquisition of the Cascadia facility, supporting its growth in the premium cannabis segment. Rubicon’s focus on quality and innovation has driven consistent revenue growth and positive Adjusted EBITDA, solidifying its position as a leader in the market.

The most recent analyst rating on (TSE:ROMJ) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Rubicon Organics stock, see the TSE:ROMJ Stock Forecast page.

Spark’s Take on TSE:ROMJ Stock

According to Spark, TipRanks’ AI Analyst, TSE:ROMJ is a Neutral.

Rubicon Organics’ overall stock score is primarily impacted by its financial performance and valuation concerns. While the company shows strong revenue growth and strategic expansion, profitability challenges and high valuation metrics weigh heavily. Technical indicators suggest potential bearish momentum, further influencing the score.

To see Spark’s full report on TSE:ROMJ stock, click here.

More about Rubicon Organics

Rubicon Organics is a leading Canadian company in the organic and premium cannabis industry. It operates with a vertically integrated model and a strong national distribution network, offering a range of trusted brands such as Simply Bare™ Organics and 1964 Supply Co.™. The company is expanding its production capacity with its Pacifica and newly acquired Cascadia facilities, positioning itself for growth in both domestic and international markets.

Average Trading Volume: 102,088

Technical Sentiment Signal: Hold

Current Market Cap: C$34.93M

For an in-depth examination of ROMJ stock, go to TipRanks’ Overview page.